UTHR Crosses Above Average Analyst Target
December 07, 2016 at 09:08 AM EST
In recent trading, shares of United Therapeutics Corp (UTHR) have crossed above the average analyst 12-month target price of $135.11, changing hands for $136.73/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..